Skip to main content
Log in

Utility of plasma dehydroepiandrosterone sulphate determination in adrenal incidentalomas

  • Published:
Journal of Endocrinological Investigation Aims and scope Submit manuscript

Abstract

To evaluate whether low DHEA-S levels are predictors of cortical origin, benignity and hormonal activity in incidentally detected adrenal masses, thirty-five patients with adrenal incidentalomas were studied. All patients were operated on and the diagnosis was histologically confirmed. Basal endocrine workup included plasma determination of cortisol before and after dexamethasone (1 mg overnight), plasma ACTH (08:00 h), 17-OH-progesterone, testosterone and potassium, standing plasma renin activity and aldosterone, supine and standing plasma noradrenaline and adrenaline. If necessary, we performed dexamethasone suppression tests at low (2 mg) and high (8 mg) doses, or the loperamide test (16 mg os) for evaluation of glucocorticoid activity and the glucagon test (1 mg iv) for exploring adrenal medulla function. Plasma DHEA-S was measured in all patients and the results were compared to those obtained in controls matched for age, sex and menopausal status. Suppression of DHEA-S was found in 11 out of 35 patients (31.5%). However, this hormonal finding occurred in 50% of the extracortical adrenal lesions, while in proven cortical adenomas (no.=19) it was detected in only 5 patients (26.3%). Sensitivity, specificity, diagnostic accuracy and positive predictive value of low DHEA-S in indicating a cortical origin of the mass were 0.27, 0.0, 0.25, and 0.80. In malignancies (no.=6) low DHEA-S levels were found in 1 out of 2 metastases and never in cortical carcinomas. Sensitivity, specificity, diagnostic accuracy and positive predictive value of low DHEA-S in indicating a benign form were 0.34, 0.83, 0.42, and 0.91. Six out of 19 patients with cortical adenomas showed signs of hypothalamic-pituitary adrenal (HPA)-axis dysfunction. Low DHEA-S levels were found in 50% of adenomas with HPA-axis abnormality and in 15.3% of adenomas without hormonal activity. Sensitivity, specificity, diagnostic accuracy, and positive predictive value of low DHEA-S levels in indicating hormonal activity of the mass were 0.50, 0.84, 0.73, and 0.60. Our data indicate that the association between low DHEA-S levels and adrenal incidentalomas is frequent. Low DHEA-S appears to be a poor predictor of hormonal activity with low sensitivity and specificity in respect of cortical origin and benignity of the mass. In conclusion, our results show that DHEA-S measurement does not offer relevant clinical information in the management of adrenal incidentalomas.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Gross M.D., Shapiro B. Clinically silent adrenal masses. J. Clin. Endocrinol. Metab. 77: 885, 1993.

    PubMed  CAS  Google Scholar 

  2. Kloos R.T., Gross M.D., Francis I.R., Korobkin M., Shapiro B. Incidentally discovered adrenal masses. Endocr. Rev. 16: 460, 1995.

    PubMed  CAS  Google Scholar 

  3. Osella G., Terzolo M., Borretta G., Magro G., Ali A., Piovesan A., Paccotti P., Angeli A. Endocrine evaluation in incidentally discovered adrenal masses (incidentalomas). J. Clin. Endocrinol. Metab. 79: 1532, 1994.

    Article  PubMed  CAS  Google Scholar 

  4. Ambrosi B., Peverelli S., Passini E., Re T., Ferrario R., Colombo P., Sartorio A., Faglia G. Abnormalities of endocrine function in patients with clinically “silent” adrenal masses. Eur. J. Endocrinol. 132: 422, 1995.

    Article  PubMed  CAS  Google Scholar 

  5. Reincke M., Nieke J., Kresti P., Saeger W., Allolio B., Winkelmann W. Preclinical Cushing’s Syndrome in adrenal “incidentalomas”: comparison with adrenal Cushing’s Syndrome. J. Clin. Endocrinol. Metab. 75: 826, 1992.

    PubMed  CAS  Google Scholar 

  6. Jockenhovel F., Kuck W., Hauffa B., Reinhardt W., Benker G., Lederbogen S., Olbircht Th., Reinwein D. Conservative and surgical management of incidentally discovered adrenal tumors (incidentalomas). J. Endocrinol. Invest. 15: 331, 1992.

    PubMed  CAS  Google Scholar 

  7. Rosen H.N., Swartz S.L. Subtle glucocorticoid excess in patients with adrenal incidentalomas. Am. J. Med. 92: 213, 1992.

    Article  PubMed  CAS  Google Scholar 

  8. Bernini G.P., Brogi G., Vivaldi M.S., Argenio G.F., Sgrò M., Moretti A., Salvetti A. 17-hydroxyprogesterone response to ACTH in bilateral and monolateral adrenal incidentalomas. J. Endocrinol. Invest. 19: 745, 1996.

    PubMed  CAS  Google Scholar 

  9. Virkkala A., Valimaki M., Pelkonen R., Huikuri K., Kahri A., Kivisaari L., Korhonen T., Salmi J., Seppala P. Endocrine abnormalities in patients with adrenal tumours incidentally discovered on computed tomography. Acta Endocrinol. (Copenh.) 121: 67, 1989.

    CAS  Google Scholar 

  10. Flecchia D., Mazza E., Carlini M., Blatto A., Olivieri F., Serra G., Camanni F., Messina M. Reduced serum levels of dehydroepiandrosterone sulphate in adrenal incidentalomas: a marker of adrenocortical tumors. Clin. Endocrinol. (Oxf.) 42: 129, 1995.

    Article  CAS  Google Scholar 

  11. Mantero F., Masini A.M., Opocher G., Giovagnetti M., Arnaldi G. Adrenal incidentaloma: An overview of hormonal data from the National Italian Study Group. Horm. Res. 47: 284, 1997.

    Article  PubMed  CAS  Google Scholar 

  12. Terzolo M., Osella G., Alì A., Borretta G., Magro G.P., Termine A., Paccotto P., Angeli A. Different patterns of steroid secretion in patients with adrenal incidentaloma. J. Clin. Endocrinol. Metab. 81: 740, 1996.

    PubMed  CAS  Google Scholar 

  13. Bencsik Z., Szabolcs I., Kovacs Z., Ferencz A., Voros A., Kaszas I., Bor K., Gonczi J., Goth M., Kovacs L., Dohan O., Szilagyi G. Low dehydroepiandrosterone sulphate (DHEA-S) level is not a good predictor of hormonal activity in non-selected patients with incidentally detected adrenal tumors. J. Clin. Endocrinol. Metab. 81: 1726, 1996.

    PubMed  CAS  Google Scholar 

  14. Yamaji T., Ishibashi M., Sekihara H., Itabashi H., Yanaihara T. Serum dehydroepiandrosterone sulphate in Cushing’s Syndrome. J. Clin. Endocrinol. Metab. 59: 1164, 1984.

    Article  PubMed  CAS  Google Scholar 

  15. Kleiber H., Rey F., Temler E., Gomez F. Dissociated recovery of cortisol and dehydroepiandrosterone sulphate after treatment for Cushing’s Syndrome. J. Endocrinol. Invest. 14: 489, 1991.

    PubMed  CAS  Google Scholar 

  16. Ambrosi B., Bochicchio D., Peverelli S., Ferrario R., Faglia G. Value of serum dehydroepiandrosterone sulphate assay in the evaluation of pituitary-adrenal insufficiency after pituitary adenomectomy. J. Endocrinol. Invest. 15: 827, 1992.

    PubMed  CAS  Google Scholar 

  17. Young J., Couzinet B., Pholsena M., Namoul K., Labrie F., Schaison G. Plasma 3β-hydroxy-Δ5-steroids in patients with congenital adrenal hyperplasia due to 21-hydroxylase deficiency. J. Clin. Endocrinol. Metab. 7: 299, 1994.

    Google Scholar 

  18. Cook D.M., Loriaux D.L. The incidental adrenal mass. Am. J. Med. 101: 88, 1996.

    Article  PubMed  CAS  Google Scholar 

  19. Parker L., Odell W. Control of adrenal androgen secretion. Endocr. Rev. 1: 392, 1980.

    Article  PubMed  CAS  Google Scholar 

  20. Sakay Y., Yanase T., Hara T., Takayanagi R., Haij M., Nawata H. Mechanism of abnormal production of adrenal androgens in patients with adrenocortical adenomas and carcinomas. J. Clin. Endocrinol. Metab. 78: 36, 1994.

    Google Scholar 

  21. Thoren M., Sjoberg H.E., Hali K., Low H. A rapid screening test for Cushing’s Syndrome. Acta Med. Scand. 198: 303, 1975.

    Article  PubMed  CAS  Google Scholar 

  22. Pasquali R., Cantabelli S., Casimirri F., Capelli M., Bartoluzzi L., Flamia R., Morselli Labate A.M., Barbara L. The hypothalamic-pituitary-adrenal axis in obese women with different patterns of body fat distribution. J. Clin. Endocrinol. Metab. 77: 341, 1993.

    PubMed  CAS  Google Scholar 

  23. Crapo L. Cushing’s Syndrome: a review of diagnostic tests. Metabolism 28: 955, 1979.

    Article  PubMed  CAS  Google Scholar 

  24. Schteingart D.E. Cushing’s Syndrome. Endocrinol. Metab. Clin. North Am. 18: 311, 1989.

    PubMed  CAS  Google Scholar 

  25. Carpenter P.C. Diagnostic evaluation of Cushing’s Syndrome. Endocrinol. Metab. Clin. North Am. 17: 445, 1988

    PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Bernini, G.P., Argenio, G.F., Vivaldi, M.S. et al. Utility of plasma dehydroepiandrosterone sulphate determination in adrenal incidentalomas. J Endocrinol Invest 21, 365–371 (1998). https://doi.org/10.1007/BF03350772

Download citation

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF03350772

Key-words

Navigation